EFFECTIVENESS OF TREATMENT WITH MEBICAR IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION

  • Lesуa Seredyuk Ivano-Frankivsk National Medical University, Ukraine
  • Igor Vakalyuk Ivano-Frankivsk National Medical University, Ukraine
Keywords: atrial fibrillation, stress, cortisol, mebicar, N-terminal fragment of the precursor of the brain natriuretic peptide (NTproBNP)

Abstract

Violation of the heart rhythm is widespread at present. Anxiety-depressive symptoms and a tendency to chronic stress leads to the depletion of the body, which contributes to arrhythmia.

The aim of the study is to assess the severity of clinical and hemodynamic indices by using anxiolytic drug mebicar.

Materials and methods. Assessment of psycho-emotional status was studied using the psychosocial scale of stress by L. Reader, PSS-10 PHQ-15 and questionnaire identification of social factors that can affect health. Determination of cortisol level in serum was carried out by immunoassay (ELISA) on the ER-500 Microplate Reader. The concentration of N-terminal fragment of the brain natriuretic peptide precursor (NTproBNP) in serum was determined by ELISA using a Biosan PST-60HL shaker.

Results. The results of the survey showed a direct dependence of the manifestation of atrial fibrillation (AF) on the level of psychoemotional stress. We found that in group 1b (standard treatment+mebicar) there were complaints of increased excitability (p<0.001), (p-reliability difference of indices before and after treatment), fatigue (p<0.001), deterioration of memory (p<0.01), appetite loss (p<0.05), sleep disturbance (p<0.001), signs of severe sweating (p<0.001), indicating the appearance of astheno-vegetative syndrome. The reduction of manifestations of high stress (p<0.01) in patients of group 1b (standard treatment+mebicar) was noted. A similar pattern was detected in the severity of anxiety in men (p<0.01).

Conclusions. Application in the complex therapy of patients with stable coronary heart disease (SIHD) in conjunction with AF anxiolytics of the benzodiazepine series (mebicar) has allowed stopping anxiety-depressive disorders. Analyzing the level of cortisol, we observed its increase depending on the degree of anxiety and depression; NT-proBNT metrics are respectively.

Downloads

Download data is not yet available.

Author Biographies

Lesуa Seredyuk, Ivano-Frankivsk National Medical University

Department of internal medicine No. 2 and nursing

 
Igor Vakalyuk, Ivano-Frankivsk National Medical University

Department of internal medicine No. 2 and nursing

 

References

Li, J., Solus, J., Chen, Q., Rho, Y. H., Milne, G., Stein, C. M., Darbar, D. (2010). Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm, 7 (4), 438–444. doi: http://doi.org/10.1016/j.hrthm.2009.12.009

McCarthy, C. P., McEvoy, J. W., Januzzi, J. L. (2018). Biomarkers in stable coronary artery disease. American Heart Journal, 196, 82–96. doi: http://doi.org/10.1016/j.ahj.2017.10.016

Hu, Y.-F., Chen, Y.-J., Lin, Y.-J., Chen, S.-A. (2015). Inflammation and the pathogenesis of atrial fibrillation. Nature Reviews Cardiology, 12 (4), 230–243. doi: http://doi.org/10.1038/nrcardio.2015.2

Yuenyongchaiwat, K. (2017). Cardiovascular response to mental stress tests and the prediction of blood pressure. Indian Journal of Psychological Medicine, 39 (4), 413–417. doi: http://doi.org/10.4103/0253-7176.211744

Polikandrioti, M., Koutelekos, I., Vasilopoulos, G., Gerogianni, G., Gourni, M., Zyga, S., Panoutsopoulos, G. (2018). Anxiety and Depression in Patients with Permanent Atrial Fibrillation: Prevalence and Associated Factors. Cardiology Research and Practice, 2018, 1–9. doi: http://doi.org/10.1155/2018/7408129

Vizier, V. A., Sadomov, A. S. (2013). Sleep deprivation and cardiovascular risk. Zaporizhia Medical Journal, 3 (78), 73–78.

Kornatsky, V. M., Mikhal'chuk, V. M., Dyachenko, L. O. (2017). The effects of stress on the development and course of diseases. Cytology of Medicine and Biology, 1 (59), 194–202.

Westcott, S. K., Beach, L. Y., Matsushita, F., Albert, C. M., Chatterjee, N., Wong, J. et. al. (2018). Relationship Between Psychosocial Stressors and Atrial Fibrillation in Women >45 Years of Age. The American Journal of Cardiology, 122 (10), 1684–1687. doi: http://doi.org/10.1016/j.amjcard.2018.07.044

Troshina, D. V., Volel, B. A., Syrkina, E. A. (2019). Stress-induced atrial fibrillation. Zhurnal Nevrologii i Psikhiatrii Im. S. S. Korsakova, 119 (1), 6–13. doi: http://doi.org/10.17116/jnevro20191190116

Garg, P. K., O’Neal, W. T., Diez‐Roux, A. V., Alonso, A., Soliman, E. Z., Heckbert, S. (2019). Negative Affect and Risk of Atrial Fibrillation: MESA. Journal of the American Heart Association, 8 (1). doi: http://doi.org/10.1161/jaha.118.010603

Kornatsky, V. M., Dorogoy, A. P., Moroz, D. M. (2015). Methodology of the contemporary prevention and early diagnosis of cardiovascular diseases. Ukrainian Cardiology Magazine, 1, 75–79.

Sravya, I. (2015). Stress: An Immortal Experience. Journal of Medical and Health Science, 4 (2). Available at: http://www.rroij.com/open-access/stress-an-immortal-experience.pdf

Walters, T. E., Wick, K., Tan, G., Mearns, M., Joseph, S. A., Morton, J. B. et. al. (2018). Psychological Distress and Suicidal Ideation in Patients With Atrial Fibrillation: Prevalence and Response to Management Strategy. Journal of the American Heart Association, 7 (18). doi: http://doi.org/10.1161/jaha.117.005502

Tarasenko, L. M. (2012). The content of glucocorticoids in biological fluids (blood serum, oral liquid) reflects the level of acute stress and the type of stress-reactivity of an organism (experimental and clinical study). Taurian Medical and Biological Journal, 15 (3 (59)), 326–329.

Khizhnyak, A. A. (2010). Antioxidant therapy in critical state medicine (literature review). Emergency Medicine, 6 (31), 71–77.

Kuznetsov, B. B. (2011). Atrial fibrillation as a pathogenetic mechanism for the development of cardioembolic stroke. Medicines of Ukraine, 4 (150), 46–49.

Rozanov, V. A. (2013). Stress and mental health (neurobiological aspects). Social and clinical psychiatry, 23 (1), 79–86.

Lioni, L., Vlachos, K., Letsas, K. P., Efremidis, M., Karlis, D., Asvestas, D. et. al. (2014). Differences in Quality of Life, Anxiety and Depression in Patients with Paroxysmal Atrial Fibrillation and Common Forms of Atrioventricular Reentry Supraventricular Tachycardias. Indian Pacing and Electrophysiology Journal, 14 (5), 250–257. doi: http://doi.org/10.1016/s0972-6292(16)30796-3

Lampert, R., Jamner, L., Burg, M., Dziura, J., Brandt, C., Liu, H. et. al. (2014). Triggering of Symptomatic Atrial Fibrillation by Negative Emotion. Journal of the American College of Cardiology, 64 (14), 1533–1534. doi: http://doi.org/10.1016/j.jacc.2014.07.959

Genik, S. M. (2007). The role of stress in the development of diseases. Galician Medical Bulletin, 4, 104–106.

Kratnov, A. E. (2011). Glutathione reductase activity in neutrophils is an important marker of oxidative stress in ischemic heart disease. Russian Immunological Journal, 1, 45–49.

Girina, O. M., Skarzhevskaya, N. A. (2010). The use of daytime tranquilizer "adaptol" in the complex therapy of patients with high cardiovascular risk: feasibility, effectiveness and safety. Ukrainian Therapeutic Journal, 1, 125–130.

Whang, W., Davidson, K. W. (2012). Global Psychological Distress and Risk of Atrial Fibrillation Among Women: The Women’s Health Study. Journal of the American Heart Association. doi: http://doi.org/10.1161/jaha.112.001107


👁 369
⬇ 130
Published
2020-09-29
How to Cite
Seredyuk, L., & Vakalyuk, I. (2020). EFFECTIVENESS OF TREATMENT WITH MEBICAR IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION. EUREKA: Health Sciences, (5), 41-50. https://doi.org/10.21303/2504-5679.2020.001385
Section
Medicine and Dentistry